Low prevalence of HER2 positivity amongst BRCA1 and BRCA2 mutation carriers and in primary BRCA screens.
Affiliation
Manchester Centre for Genomic Medicine, St Mary's Hospital, Manchester Academic Health Sciences Centre (MAHSC)Issue Date
2016-02-18
Metadata
Show full item recordCitation
Low prevalence of HER2 positivity amongst BRCA1 and BRCA2 mutation carriers and in primary BRCA screens. 2016, 155 (3):597-601 Breast Cancer Res TreatJournal
Breast Cancer Research and TreatmentDOI
10.1007/s10549-016-3697-zAdditional Links
http://link.springer.com/10.1007/s10549-016-3697-zType
ArticleLanguage
enISSN
0167-68061573-7217
ae974a485f413a2113503eed53cd6c53
10.1007/s10549-016-3697-z